Rewiring pathology for precision medicine
Proscia is a Philadelphia-based digital pathology software company founded in 2014 by David West, Coleman Stavish, and Nathan Buchbinder. The company's Concentriq platform is an enterprise digital pathology system used by more than 12,000 pathologists and scientists daily at reference labs, academic medical centers, CROs, and 16 of the top 20 global pharma companies. Concentriq offers purpose-built products for life sciences research, anatomic pathology digitization, and FDA-cleared primary diagnosis. Proscia also offers Aperture, a precision medicine solution for drug development and real-world evidence generation.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account